Viewing StudyNCT02495415



Ignite Creation Date: 2024-05-06 @ 7:12 AM
Last Modification Date: 2024-10-26 @ 11:46 AM
Study NCT ID: NCT02495415
Status: UNKNOWN
Last Update Posted: 2019-07-23
First Post: 2015-07-07

Brief Title: Trial of Intravenous Fenretinide Emulsion for Patients With RelapsedRefractory Peripheral T-cell Lymphomas
Sponsor:
Organization: CerRx Inc

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 140
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: